Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Psychol Med. 2020 Jan;50(2):324-333. doi: 10.1017/S003329171900014X. Epub 2019 Feb 7.
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) introduced somatic symptom and related disorders (SSD) to improve the diagnosis of somatoform disorders. It is unclear whether existing questionnaires are useful to identify patients with SSD. Our study investigates the diagnostic accuracy of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8) in combination with the Somatic Symptom Disorder - B Criteria Scale (SSD-12).
For this cross-sectional study, participants were recruited from a psychosomatic outpatient clinic. PHQ-15, SSS-8, and SSD-12 were administered and compared with SSD criteria from a diagnostic interview. Sensitivity and specificity were calculated for optimal individual and combined cutpoints. Receiver operator curves were created and area under the curve (AUC) analyses assessed.
Data of n = 372 patients [31.2% male, mean age: 39.3 years (s.d. = 13.6)] were analyzed. A total of 56.2% fulfilled the SSD criteria. Diagnostic accuracy was moderate for each questionnaire (PHQ-15: AUC = 0.70; 95% CI = 0.65-0.76; SSS-8: AUC = 0.71; 95% CI = 0.66-0.77; SSD-12: AUC = 0.74; 95% CI = 0.69-0.80). Combining questionnaires improved diagnostic accuracy (PHQ-15 + SSD-12: AUC = 0.77; 95% CI = 0.72-0.82; SSS-8 + SSD-12: AUC = 0.79; 95% CI = 0.74-0.84). Optimal combined cutpoints were ⩾9 for the PHQ-15 or SSS-8, and ⩾23 for the SSD-12 (sensitivity and specificity = 69% and 70%).
The combination of the PHQ-15 or SSS-8 with the SSD-12 provides an easy-to-use and time- and cost-efficient opportunity to identify persons at risk for SSD. If systematically applied in routine care, effective screening and subsequent treatment might help to improve quality of life and reduce health care excess costs.
《精神障碍诊断与统计手册》(DSM-5)第五版引入了躯体症状及相关障碍(SSD),以改善躯体形式障碍的诊断。目前尚不清楚现有的问卷是否有助于识别 SSD 患者。本研究旨在调查患者健康问卷-15 项(PHQ-15)和躯体症状量表-8 项(SSS-8)联合躯体症状障碍 - B 标准量表(SSD-12)在诊断 SSD 方面的准确性。
本横断面研究招募了来自身心门诊的参与者。对 PHQ-15、SSS-8 和 SSD-12 进行了评估,并与诊断访谈中的 SSD 标准进行了比较。计算了最佳个体和联合切点的灵敏度和特异性。绘制了接受者操作特征曲线,并对曲线下面积(AUC)进行了分析。
共分析了 372 名患者的数据[男性占 31.2%,平均年龄:39.3 岁(标准差=13.6)]。共有 56.2%的患者符合 SSD 标准。每个问卷的诊断准确性均为中等(PHQ-15:AUC=0.70;95%CI=0.65-0.76;SSS-8:AUC=0.71;95%CI=0.66-0.77;SSD-12:AUC=0.74;95%CI=0.69-0.80)。联合使用问卷可提高诊断准确性(PHQ-15+SSD-12:AUC=0.77;95%CI=0.72-0.82;SSS-8+SSD-12:AUC=0.79;95%CI=0.74-0.84)。PHQ-15 或 SSS-8 ⩾9、SSD-12 ⩾23 为最佳联合切点(灵敏度和特异性分别为 69%和 70%)。
PHQ-15 或 SSS-8 联合 SSD-12 为识别 SSD 风险人群提供了一种简便、省时、经济高效的机会。如果在常规护理中系统应用,有效的筛查和随后的治疗可能有助于提高生活质量并降低医疗保健过度费用。